Definitive Healthcare

The firm sells a SaaS platform that aggregates and analyzes data on US healthcare providers, payers, and life sciences organizations. Subscribers use it for deal origination — identifying acquisition targets, mapping physician referral networks, and sizing market opportunities before committing capital. The platform replaces the manual provider surveys and public record searches that used to dominate healthcare services diligence.

Advent International took Definitive Healthcare private in December 2024 in a deal valued at approximately $1.6 billion. The acquisition embeds a proprietary healthcare data asset inside one of the world's largest private equity firms. Advent portfolio companies and deal teams gain preferred access to Definitive's analytics, while the platform continues selling to external private equity and corporate clients — creating an information edge in healthcare services dealmaking that competitors cannot easily replicate.

The platform tracks over 2.3 million healthcare professionals, 9,300 hospitals, 1.4 million physician profiles, 900 payers, and detailed claims-based referral patterns. Data is refreshed daily. Modules cover physician network analytics, claims-based market intelligence, and predictive physician affiliation modeling. The firm also maintains European physician and key opinion leader data through its Monocl subsidiary in Sweden.

It is a data and analytics company first, not a healthcare provider. The firm does not own or operate hospitals, physician practices, or payers. It compiles and licenses commercial intelligence on the healthcare ecosystem, serving private equity firms, healthcare corporate development teams, and life sciences companies that make capital allocation and M&A decisions.

The firm operates in healthcare commercial intelligence, a niche that includes competitors like IQVIA's commercial data division, Clarivate, and smaller vertical data providers. Definitive Healthcare differentiates through proprietary physician-linkage algorithms and referral-pattern analytics that connect clinical relationships to market share dynamics — the specific intelligence private equity firms need for platform investments and add-on acquisitions.